dc.contributor.author |
Machlaurin, Afifah |
|
dc.contributor.author |
Satibi, Satibi |
|
dc.contributor.author |
Yasin, Nanang Munif |
|
dc.date.accessioned |
2018-01-22T04:15:08Z |
|
dc.date.available |
2018-01-22T04:15:08Z |
|
dc.date.issued |
2018-01-22 |
|
dc.identifier.issn |
0125-9695 |
|
dc.identifier.uri |
http://ura.unej.ac.id/123456789/67811 |
|
dc.description.abstract |
SKKD No. 1309/UN25.5.1/TU.3/2017 "PENAMBAHAN CIPROFLOKSACIN INTRAVENA TERHADAP CEFTR]AKSON SEBAGAI TERAPI ANTIBIOTIK EMPIRIS PADA PASIEN PNEUMONIA RAWAT INAP : PERBANDINGAN BIAYA DAN EFEKTIVITAS (ADDING ]NTRAVENOUS CIPROFLOXACIN INTO CEFTRIAXONE AS AN EMPIRICAL ANTIBIOTIC TREATMENT IN HOSPITALIZED PNEUMONIA: A COMPARATIVE STUDY OF COST AND EFFECTIVENESS)" |
en_US |
dc.language.iso |
id |
en_US |
dc.subject |
SKKD No. 1309/UN25.5.1/TU.3/2017 "PENAMBAHAN CIPROFLOKSACIN INTRAVENA TERHADAP CEFTR]AKSON SEBAGAI TERAPI ANTIBIOTIK EMPIRIS PADA PASIEN PNEUMONIA RAWAT INAP : PERBANDINGAN BIAYA DAN EFEKTIVITAS (ADDING ]NTRAVENOUS CIPROFLOXACIN INTO CEFTRIAXONE AS AN EMPIRICAL ANTIBIOTIC TREATMENT IN HOSPITALIZED PNEUMONIA: A COMPARATIVE STUDY OF COST AND EFFECTIVENESS)" |
en_US |
dc.title |
SKKD No. 1309/UN25.5.1/TU.3/2017 "PENAMBAHAN CIPROFLOKSACIN INTRAVENA TERHADAP CEFTR]AKSON SEBAGAI TERAPI ANTIBIOTIK EMPIRIS PADA PASIEN PNEUMONIA RAWAT INAP : PERBANDINGAN BIAYA DAN EFEKTIVITAS (ADDING ]NTRAVENOUS CIPROFLOXACIN INTO CEFTRIAXONE AS AN EMPIRICAL ANTIBIOTIC TREATMENT IN HOSPITALIZED PNEUMONIA: A COMPARATIVE STUDY OF COST AND EFFECTIVENESS)" |
en_US |
dc.type |
Article |
en_US |